Guangdong Hybribio Biotech Co.,Ltd. (SHE:300639)
China · Delayed Price · Currency is CNY 5.77
+0.04 (0.70%)
Nov 2, 2026, 3:04 PM CST
SHE:300639 Balance Sheet
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Equivalents | 755.99 | 798.56 | 712.36 | 764.93 | 1,025 | 521.97 |
Short-Term Investments | - | - | 250.29 | - | - | - |
Trading Asset Securities | 270.16 | 240.15 | 0.63 | 307.05 | 387.06 | 677.14 |
Cash & Short-Term Investments | 1,026 | 1,039 | 963.27 | 1,072 | 1,412 | 1,199 |
Cash Growth | 9.30% | 7.83% | -10.14% | -24.07% | 17.74% | -4.14% |
Accounts Receivable | 629.81 | 701.4 | 1,099 | 1,891 | 2,725 | 1,116 |
Other Receivables | 8.17 | 14.45 | 10.98 | 13.56 | 16.32 | 14.53 |
Receivables | 637.98 | 715.84 | 1,110 | 1,904 | 2,742 | 1,131 |
Inventory | 69.75 | 61.86 | 65.66 | 99.56 | 118.74 | 147.14 |
Prepaid Expenses | - | 0.05 | 0.01 | 5.1 | 15.54 | 23.37 |
Other Current Assets | 82.42 | 77.64 | 87.09 | 96.13 | 112.44 | 51.95 |
Total Current Assets | 1,816 | 1,894 | 2,226 | 3,177 | 4,400 | 2,552 |
Property, Plant & Equipment | 1,268 | 1,315 | 1,408 | 1,437 | 1,317 | 1,168 |
Long-Term Investments | 650.56 | 531.93 | 545.71 | 533.12 | 521.98 | 273.81 |
Other Intangible Assets | 301.25 | 252.7 | 259.28 | 249.58 | 185.21 | 100.14 |
Long-Term Deferred Tax Assets | 58.56 | 66.77 | 86.32 | 195.35 | 180.25 | 29.2 |
Long-Term Deferred Charges | 52.78 | 56 | 60.9 | 79.95 | 81.61 | 82.62 |
Other Long-Term Assets | 20.61 | 31.54 | 37.61 | 53.5 | 54.89 | 25.58 |
Total Assets | 4,173 | 4,148 | 4,623 | 5,726 | 6,741 | 4,231 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Accounts Payable | 86.4 | 86.36 | 106.75 | 143.67 | 466.69 | 221.15 |
Accrued Expenses | 43.45 | 218.02 | 262.62 | 85.83 | 399.86 | 174.96 |
Short-Term Debt | 10.5 | 6.82 | 21.63 | 2.12 | 98.48 | 151.5 |
Current Portion of Long-Term Debt | 1.56 | 0.05 | - | - | - | - |
Current Portion of Leases | - | 6.21 | 7.91 | 8.86 | 10.48 | 6.79 |
Current Income Taxes Payable | 10.3 | 3.59 | 8.3 | 78.1 | 352.71 | 94.88 |
Current Unearned Revenue | 12.16 | 10.96 | 14.86 | 8.93 | 22.16 | 13.16 |
Other Current Liabilities | 147.14 | 20.31 | 19.49 | 180.4 | 12.46 | 15.15 |
Total Current Liabilities | 311.51 | 352.33 | 441.55 | 507.92 | 1,363 | 677.59 |
Long-Term Debt | 164.26 | 73.24 | 52.79 | 28.27 | - | - |
Long-Term Leases | 1.59 | 3.24 | 5.19 | 17.4 | 30.53 | 26.86 |
Long-Term Unearned Revenue | 5.95 | 6.94 | 9.15 | 11.82 | 14.13 | 16.56 |
Long-Term Deferred Tax Liabilities | 80.87 | 47.87 | 67.07 | 61.6 | 106.14 | 35.36 |
Other Long-Term Liabilities | 1.74 | 2.25 | 0.69 | 0.05 | - | - |
Total Liabilities | 565.91 | 485.86 | 576.44 | 627.05 | 1,514 | 756.37 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Common Stock | 646.5 | 646.5 | 646.5 | 649.15 | 439.52 | 293.89 |
Additional Paid-In Capital | 612.11 | 667.11 | 785.49 | 877.52 | 1,190 | 1,280 |
Retained Earnings | 2,490 | 2,420 | 2,551 | 3,247 | 3,258 | 1,634 |
Treasury Stock | -235.15 | -110.15 | -65.13 | -100 | -149.99 | -99.99 |
Comprehensive Income & Other | 168.36 | 125.1 | 191.85 | 187.26 | 169.84 | 86.73 |
Total Common Equity | 3,682 | 3,748 | 4,109 | 4,861 | 4,907 | 3,194 |
Minority Interest | -74.28 | -86.54 | -62.9 | 237.46 | 320.38 | 280.63 |
Shareholders' Equity | 3,607 | 3,662 | 4,047 | 5,099 | 5,228 | 3,475 |
Total Liabilities & Equity | 4,173 | 4,148 | 4,623 | 5,726 | 6,741 | 4,231 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Sep '26 Sep 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Total Debt | 177.91 | 89.56 | 87.51 | 56.65 | 139.49 | 185.15 |
Net Cash (Debt) | 848.24 | 949.15 | 875.76 | 1,015 | 1,272 | 1,014 |
Net Cash Growth | 1.88% | 8.38% | -13.75% | -20.20% | 25.48% | -13.74% |
Net Cash Per Share | 1.35 | 1.52 | 1.36 | - | 1.93 | 1.54 |
Filing Date Shares Outstanding | 638.08 | 627.62 | 635.3 | - | 651.68 | 655.3 |
Total Common Shares Outstanding | 638.08 | 627.62 | 635.3 | - | 651.68 | 655.3 |
Working Capital | 1,505 | 1,542 | 1,784 | 2,669 | 3,037 | 1,875 |
Book Value Per Share | 5.77 | 5.97 | 6.47 | - | 7.53 | 4.87 |
Tangible Book Value | 3,375 | 3,496 | 3,850 | 4,612 | 4,722 | 3,094 |
Tangible Book Value Per Share | 5.29 | 5.57 | 6.06 | - | 7.25 | 4.72 |
Buildings | - | 1,357 | 1,115 | 1,070 | 991.09 | 786.57 |
Machinery | - | 702.56 | 701.8 | 683.89 | 600.83 | 521.92 |
Construction In Progress | - | 32.18 | 232.59 | 171.38 | 58.62 | 38.29 |